It promotes the expression of oncogenic proteins that enhance cancer cell growth, survival, and progression such as cyclin D1, c-Myc, and insulin-like growth factor 1, while inhibiting cell cycle arrest proteins such as p21 [7, 29]. The gene discussed is MYC; the disease is cancer.